FGF21 and type 2 diabetes mellitus: Increased plasma FGF21 levels and hepatic expression in KD-fed mice is probably secondary to hepatic fat accumulation and may represent a compensatory mechanism to counteract hepatic insulin resistance, similar to what is seen in patients with obesity, type 2 diabetes and NAFLD [38, 39].